Open access
Open access
Powered by Google Translator Translator

Cohort Study | Ibrutinib is associated with increased cardiovascular events and major bleeding in older CLL patients

8 May, 2023 | 12:59h | UTC

Ibrutinib Is Associated With Increased Cardiovascular Events and Major Bleeding in Older CLL Patients – JACC: CardioOncology


Commentary on Twitter


Stay Updated in Your Specialty

Telegram Channels

WhatsApp alerts 10-day free trial

No spam, just news.